Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Could Charles River (CRL) Using Locus Cell Tie-Up to Reframe Its Asia-Pacific Growth Strategy?
Charles River Laboratories recently signed an MoU with Locus Cell Co. to collaborate on advanced therapy development and testing in the Asia-Pacific region. This partnership aims to strengthen Charles River’s position in the growing cell and gene therapy market, though its impact on near-term revenue growth and competition remains to be seen. The company’s investment narrative projects significant revenue and earnings growth by 2028, but some analysts hold a more pessimistic view.